It is known that cells from any tissue involved in CCM normally upregulate MMP14 at the leading edge, and thus, increase activation of downstream secreted MMPs, such as MMP2, MMP13 and MMP1 [16,26,35,41,53]. This evidence concerns the gene MMP2 and cerebral cavernous malformation.